Physician
Touchette Regional Hospital INC
Touchette Regional Hospital INC was paid $2.06M by Medicaid between Jan 2018 and Jun 2020, across 108 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 41% of everything it billed.
33Billing provider infoTOUCHETTE REGIONAL HOSPITAL INC
CAHOKIA HEIGHTS, IL 62207
CAHOKIA HEIGHTS, IL 62207
33aNPI1922019926assigned 08/11/2006
33bProvider typeDiagnostic Radiology Physician
28Total paid$2.06M
24GClaims140,103
24DCodes billed108
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other Diagnostic Radiology Physician providers in Illinois
Rank by total paid#2 of 1,075
Median peer was paid$76K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,334 | $423K | |
| 2019 | 78,037 | $1.21M | |
| 2020 | 27,732 | $432K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 41% | 8,415 | 2,080 | $856K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 15% | 5,611 | 4,749 | $317K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 6.2% | 1,870 | 1,331 | $129K |
| 97162 | 5.1% | 946 | 794 | $104K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.0% | 7,717 | 6,715 | $102K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 7,719 | 6,718 | $96K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.9% | 1,030 | 980 | $59K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.2% | 879 | 795 | $44K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 2,998 | 2,310 | $37K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 6,481 | 5,759 | $32K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.5% | 8,130 | 6,913 | $32K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.5% | 1,351 | 1,062 | $32K |
96 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,755 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,367 | $11K |
| 97163 | <1% | 102 | $11K | |
| 80074 | <1% | 1,599 | $10K | |
| 83655 | <1% | 1,018 | $10K | |
| 86787 | <1% | 1,332 | $10K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,363 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 146 | $8K |
| 87481 | <1% | 1,373 | $8K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,746 | $7K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,242 | $7K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 814 | $6K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 765 | $6K |
| 94060 | <1% | 158 | $6K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,302 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 67 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 234 | $5K |
| 84439 | <1% | 3,149 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 640 | $4K |
| 86696 | <1% | 956 | $4K | |
| 87340 | <1% | 2,141 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 288 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,704 | $3K |
| 80061 | Lipid panel | <1% | 6,507 | $3K |
| 86336 | <1% | 288 | $3K | |
| 73630 | <1% | 352 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 355 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,276 | $3K |
| 86592 | <1% | 4,721 | $3K | |
| 86695 | <1% | 638 | $3K | |
| 84702 | <1% | 1,005 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 60 | $2K |
| 82951 | <1% | 404 | $2K | |
| 84442 | <1% | 507 | $2K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 313 | $2K |
| 82607 | <1% | 293 | $1K | |
| 83021 | <1% | 712 | $1K | |
| 72100 | <1% | 135 | $1K | |
| 86803 | <1% | 768 | $1K | |
| 73562 | <1% | 183 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 42 | $1K |
| 86003 | <1% | 54 | $1K | |
| 83550 | <1% | 387 | $1K | |
| 82105 | <1% | 374 | $1K | |
| 84153 | <1% | 145 | $1K | |
| 87081 | <1% | 646 | $1K | |
| 86762 | <1% | 1,215 | $1K | |
| 81001 | <1% | 1,635 | $879.77 | |
| 85018 | <1% | 1,535 | $826.91 | |
| 85610 | <1% | 718 | $759.50 | |
| 73610 | <1% | 59 | $725.98 | |
| 85027 | <1% | 1,189 | $703.03 | |
| 81003 | <1% | 1,685 | $698.52 | |
| 84403 | <1% | 30 | $688.80 | |
| 86900 | <1% | 1,275 | $659.63 | |
| 85660 | <1% | 742 | $615.89 | |
| 85014 | <1% | 944 | $576.30 | |
| 73030 | <1% | 67 | $561.05 | |
| 87186 | <1% | 69 | $494.56 | |
| 86901 | <1% | 1,275 | $493.02 | |
| 86850 | <1% | 1,247 | $461.72 | |
| 97010 | <1% | 324 | $384.20 | |
| 82677 | <1% | 255 | $377.91 | |
| 84146 | <1% | 182 | $363.78 | |
| 82043 | <1% | 777 | $337.93 | |
| 83001 | <1% | 47 | $265.35 | |
| 82785 | <1% | 173 | $243.49 | |
| 73502 | <1% | 15 | $240.60 | |
| 83013 | <1% | 32 | $235.15 | |
| 86038 | <1% | 35 | $230.55 | |
| 82570 | <1% | 161 | $220.43 | |
| 86593 | <1% | 405 | $214.04 | |
| 82950 | <1% | 340 | $213.43 | |
| 82728 | <1% | 233 | $209.10 | |
| 83540 | <1% | 407 | $193.06 | |
| 85730 | <1% | 147 | $171.62 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 25 | $127.32 |
| 86705 | <1% | 44 | $119.85 | |
| 84550 | <1% | 199 | $78.90 | |
| 82977 | <1% | 62 | $78.75 | |
| 87150 | <1% | 174 | $72.20 | |
| 85651 | <1% | 223 | $49.28 | |
| 82465 | <1% | 88 | $41.56 | |
| 80076 | <1% | 33 | $34.92 | |
| 86140 | <1% | 32 | $31.99 | |
| 86431 | <1% | 13 | $28.20 | |
| 85652 | <1% | 16 | $17.73 | |
| 87088 | <1% | 22 | $16.50 | |
| 84450 | <1% | 64 | $11.30 | |
| 82248 | <1% | 13 | $6.81 | |
| 84156 | <1% | 16 | $6.72 | |
| 84155 | <1% | 12 | $3.50 | |
| 84460 | 0% | 120 | $0.00 | |
| 85045 | 0% | 13 | $0.00 | |
| 80346 | 0% | 23 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 120 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOACHER, BRAD (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Touchette Regional Hospital, INC. | Cahokia Heights, IL | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.